Atypical presentation of adult T-cell leukaemia/lymphoma due to HTLV-1: Prurigo nodularis lasting twelve years followed by an acute micropapular eruption

Acta Dermato-Venereologica

Volumn 90, Issue 3, 2010, Pages 287-290

  Duval, Arnaud ^a   Rivet, Jacqueline ^a   Moulonguet, Isabelle ^a   Cassar, Olivier ^b   Agbalika, Félix ^a   Wallach, Daniel ^c   Gessain, Antoine ^b   Petit, Antoine ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c Université Denis Diderot Paris 7 ^*  (France)

Author keywords

ATLL; HTLV 1; Human T cell leukaemia lymphoma; Prurigo; Pruritus; Skin

Indexed keywords

ALPHA INTERFERON; BETAMETHASONE DIPROPIONATE; DITHRANOL; THALIDOMIDE; ZIDOVUDINE;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; MALE; NONHUMAN; PAPULE; PRIORITY JOURNAL; PRURIGO; PRURIGO NODULARIS; RASH; SKIN BIOPSY; T CELL LEUKEMIA;

ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON ALFA-2A; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PRURIGO; SKIN; TIME FACTORS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 77953435993     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0846     Document Type: Article

References (15)

1. Lee MR, Shumack S. Prurigo nodularis: a review. Australas J Dermatol 2005; 46: 211-218.
2. Verdonck K, González E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007; 7: 266-281.
3. Pezeshkpoor F, Yazdanpanah MJ, Shirdel A. Specific cutaneous manifestations in adult T-cell leukemia/lymphoma. Int J Dermatol 2008; 47: 359-362.
4. Setoyama M, Mizoguchi S, Kanzaki T. Prurigo as a clinical prodrome to adult T-cell leukaemia/lymphoma. Br J Dermatol 1998; 138: 137-140.
5. Araujo AQ, Silva MT. The HTLV-1 neurological complex. Lancet Neurol 2006; 5:1068-1076.
6. Rowland Payne CM, Wilkinson JD, McKee PH, Jurecka W, Black MM, et al. Nodular prurigo - a clinicopathological study of 46 patients. Br J Dermatol 1985; 113: 431-439.\
7. Bharati A, Wilson NJ. Peripheral neuropathy associated with nodular prurigo. Clin Exp Dermatol 2007; 32: 67-70.
8. Bazarbachi A, Ghez D, Lepelletier Y, Nasr R, de Thé H, El-Sabban ME, Hermine O. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 2004; 5: 664-672.
9. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79: 428-437.
10. Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol 2005; 78: 232-239.
11. Cavrois M, Wain-Hobson S, Gessain A Plumelle Y, Wattel E. Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. Blood 1996; 88: 4646-4650. (Pubitemid 26419148)
12. Gessain A, Moulonguet I, Flageul B, Perrin P, Capesius C, D'Agay MF, et al. Cutaneous type of adult T cell leukemia/lymphoma in a French West Indian woman. Clonal rearrangement of T-cell receptor beta and gamma genes and monoclonal integration of HTLV-I proviral DNA in the skin infiltrate. J Am Acad Dermatol 1990; 23: 994-1000. (Pubitemid 20364353)
13. Smith SM, Grinblatt D, Johnson JL, Niedzwiecki D, Rizzieri D, Bartlett NL, et al. Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Br J Haematol 2008; 140: 313-319.
14. Damaj G, Bouabdallah R, Vey N, Bilger K, Mohty M, Gastaut JA. Single-agent thalidomide induces response in T-cell lymphoma. Eur J Haematol 2005; 74: 169-171.
15. Winkelmann RK, Connolly SM, Doyle JA, PadilhaGoncalves A. Thalidomide treatment of prurigo nodularis. Acta Derm Venereol 1984; 64: 412-417.